Glucocentric Drugs in Cardiovascular Disease Protection and Heart Failure

By sjmartinez • December 24, 2022

Talha KM, Fonarow GC, Virani SS, Butler J. Glucocentric Drugs in Cardiovascular Disease Protection and Heart Failure. Methodist Debakey Cardiovasc J. 2022 Dec 6;18(5):40-53. doi: 10.14797/mdcvj.1155. PMID: 36561085; PMCID: PMC9733124.

Tags: Cardiology/Epi, cardiovascular disease, glucagon-like peptide 1 receptor agonist, heart failure, prevention, Publications, sodium-glucose cotransporter-2 inhibitor

Hemodynamic significance of coronary anomalies: Computed tomography-based fractional flow reserve (CT-FFR) as an Adjudicator

Golub I, Benzing T, Kianoush S, Krishnan S, Ichikawa K, Budoff MJ. Hemodynamic significance of coronary anomalies: Computed tomography-based fractional flow reserve (CT-FFR) as an[...]

Cardiac blood vessels and irreversible electroporation: findings from pulsed field ablation

Chinyere IR, Mori S, Hutchinson MD. Cardiac blood vessels and irreversible electroporation: findings from pulsed field ablation. Vessel Plus. 2024;8:7. doi: 10.20517/2574-1209.2023.80. Epub 2024 Jan[...]

Impact of COVID-19 Pandemic on Sex and Racial Disparities in Chest Pain Presentation and Management Through the Emergency Department

Hu X, Fanous E, Jackson NJ, Daso GI, Liang I, McCullough LB, Cooper RJ, Horwich TB, Watson KE, Shah JB, Shahandeh N, Calfon Press MA.[...]